Subscribe

Value Propositions

  • Application and Population Management System Undergoing Testing for the Management of Flares in Patients with Rheumatoid Arthritis
  • Humana Adds MDLIVE Telemedicine Technology Benefit to Select Medicare Advantage Plans
  • Applications Being Developed to Provide Patients with Timely Drug Cost Information
  • Routine Monitoring of Drug Levels and Antidrug Antibodies Benefits Cost, Improves Treatment Decision-Making
  • Switching Between Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis
  • Tofacitinib Treatment Demonstrates Cost Benefits in Patients with Rheumatoid Arthritis
  • Portable Device Offers Easier, Cost-Effective Approach to Gout Diagnosis
  • Efficacy and Safety Maintained for Up to 5 Years with Tocilizumab Therapy
  • First Ever Treatment Guidelines for Managing Rheumatologic Manifestations of Sjögren’s Syndrome
  • Short-Term Use of Soft Lateral Wedge Arch Support Significantly Reduces Pain in Patients with Knee Osteoarthritis
  • Tocilizumab Effective, Highly Retentive in Patients with Rheumatoid Arthritis
  • Cardiovascular Screening Cost-Effective in Patients with Rheumatoid Arthritis
  • Decernotinib, DMARD Combination Reduces Symptoms, Signs of Rheumatoid Arthritis
  • Efficacy of Etanercept, Methotrexate Combination Independent of Methotrexate Dosage
Sanofi US has announced that Winthrop US, its generic division, will begin providing an authorized generic version of Arava tablets indicated for the treatment of active rheumatoid arthritis in adults.
Page 1 of 21
Results 1 - 10 of 204
  • American Health & Drug Benefits
  • Lynx CME
  • Value-Based Care in Myeloma
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology